Postmarketing surveillance of lovastatin and simvastatin exposure during pregnancy (Q71840439)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8946557%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

title

Postmarketing surveillance of lovastatin and simvastatin exposure during pregnancy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8946557%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

1 reference

Manson JM

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8946557%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

Freyssinges C

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8946557%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

Ducrocq MB

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8946557%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

Stephenson WP

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8946557%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

publication date

1 November 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8946557%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

published in

Reproductive Toxicology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8946557%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8946557%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8946557%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

page(s)

439-446

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8946557%20AND%20SRC:MED&resulttype=core&format=json

Cholesterol-lowering effect of mevinolin, an inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme a reductase, in healthy volunteers

21 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2896%2900130-X

7 January 2021

HMG-CoA reductase inhibitors for treatment of hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2896%2900130-X

7 January 2021

Maternal hyperlipidemia in pregnancy.

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2896%2900130-X

7 January 2021

Mevalonate supplementation in pregnant rats suppresses the teratogenicity of mevinolinic acid, an inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme a reductase

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2896%2900130-X

7 January 2021

Congenital abnormalities (VATER) in baby born to mother using lovastatin

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2896%2900130-X

7 January 2021

The VATER association. Vertebral defects, Anal atresia, T-E fistula with esophageal atresia, Radial and Renal dysplasia: a spectrum of associated defects

1 reference

https://api.crossref.org/works/10.1016%2FS0890-6238%2896%2900130-X

7 January 2021

10.1016/S0890-6238(96)00130-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8946557%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

1 reference